Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Infection
Published in: Infection 2/2020

01-04-2020 | Antibiotic | Correspondence

Dalbavancin as a second-line treatment in methicillin-resistant Staphylococcus aureus prosthetic vascular graft infection

Authors: Arturo Ciccullo, Gabriele Giuliano, Francesco Vladimiro Segala, Eleonora Taddei, Damiano Farinacci, Federico Pallavicini

Published in: Infection | Issue 2/2020

Login to get access

Excerpt

Dear Sir, …
Literature
1.
2.
Bork JT, Heil EL, Berry S, et al. Dalbavancin use in vulnerable patients receiving outpatient parenteral antibiotic therapy for invasive gram-positive infections. Infect Dis Ther. 2019;8:171–84.CrossRef
3.
4.
5.
Metadata
Title
Dalbavancin as a second-line treatment in methicillin-resistant Staphylococcus aureus prosthetic vascular graft infection
Authors
Arturo Ciccullo
Gabriele Giuliano
Francesco Vladimiro Segala
Eleonora Taddei
Damiano Farinacci
Federico Pallavicini
Publication date
01-04-2020
Publisher
Springer Berlin Heidelberg
Published in
Infection / Issue 2/2020
Print ISSN: 0300-8126
Electronic ISSN: 1439-0973
DOI
https://doi.org/10.1007/s15010-019-01379-2

Other articles of this Issue 2/2020

Infection 2/2020 Go to the issue

Original Paper

Bloodstream infections caused by Escherichia coli carrying mcr-1 gene in hospitalized patients in northern Italy from 2012 to 2018

Review

Aspergillus flavus malignant external otitis in a diabetic patient: case report and literature review

Correspondence

Setting an appropriately high enough bar when evaluating the safety of antiretroviral drugs for use in pregnancy

Editorial

Successful containment of COVID-19: the WHO-Report on the COVID-19 outbreak in China

Images in Infection

Lymphadenitis and aortitis due to Brucella melitensis infection

Original Paper

Pregnancy and neonatal outcomes in women with HIV-1 exposed to integrase inhibitors, protease inhibitors and non-nucleoside reverse transcriptase inhibitors: an observational study

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits